Modulation of tryptase and histamine release from human lung mast cells by protease inhibitors

Asian Pacific Journal of Allergy and Immunology

Volumn 22, Issue 4, 2004, Pages 205-212

  He, Shaoheng ^a   Xie, Hua ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMASTATIN; CALCIMYCIN; HISTAMINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; PROTAMINE; TOSYLLYSYL CHLOROMETHYL KETONE; TOSYLPHENYLALANYL CHLOROMETHYL KETONE; TRYPTASE;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME RELEASE; HISTAMINE RELEASE; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL; MAST CELL;

FEMALE; HISTAMINE RELEASE; HUMANS; IMMUNOGLOBULIN E; LUNG; MALE; MAST CELLS; PROTEASE INHIBITORS; SERINE ENDOPEPTIDASES; TOSYLLYSINE CHLOROMETHYL KETONE; TOSYLPHENYLALANYL CHLOROMETHYL KETONE; TRYPTASES;

EID: 14844358197     PISSN: 0125877X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Carroll NG, Mutavdzic S, James AL. Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma. Thorax 2002; 57: 677-82.
2. MacFarlane AJ, Kon OM, Smith SJ, Zeibecoglou K, Khan LN, Barata LT, McEuen AR, Buckley MG, Walls AF, Meng Q. Humbert M, Barnes NC, Robinson DS, Ying S, Kay AB. Basophils, eosinophils, and mast cells in atopic and nonatopic asthma and in late-phase allergic reactions in the lung and skin. J Allergy Clin Immunol 2000; 105: 99-107.
3. Braunstahl GJ, Overbeek SE, Fokkens WJ, Kleinjan A, McEuen AR, Walls AF, Hoogsteden HC, Prins JB. Segmental bronchoprovocation in allergic rhinitis patients affects mast cell and basophil numbers in nasal and bronchial mucosa. Am J Respir Crit Care Med 2001; 164: 858-65.
4. Jacobson MR, Juliusson S, Lowhagen O, Balder B, Kay AB, Durham SR. Effect of topical corticosteroids on seasonal increases in epithelial eosinophils and mast cells in allergic rhinitis: a comparison of nasal brush and biopsy methods. Clin Exp Allergy 1999; 29: 1347-55.
5. KleinJan A, McEuen AR, Dijkstra MD, Buckley MG, Walls AF, Fokkens WJ. Basophil and eosinophil accumulation and mast cell degranulation in the nasal mucosa of patients with hay fever after local allergen provocation. J Allergy Clin Immunol 2000; 106: 677-86.
6. Walls AF, He S, Buckley MG, McEuen AR. Roles of the mast cell and basophil in asthma. Clin Exp Allergy Rev 2001; 1: 68-72.
7. Schwartz LB. Tryptase from human mast cells: biochemistry, biology and clinical utility: In: Schwartz LB, editor. Neutral proteases of mast cells. Basel, Karger: Monogr Allergy; 1990; pp. 90-113.
8. McEuen AR, He S, Brander ML, Walls, AF. Guinea pig lung tryptase: localisation to mast cells and characterisation of the partially purified enzyme. Biochem Pharmacol 1996; 52: 331-40.
9. Broide DH, Gleich GJ, Cuomo AJ, Coburn DA, Federman EC, Schwartz LB, Wasserman SI. Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway. J Allergy Clin Immunol 1991; 88: 637-48.
10. Swystun VA, Gordon JR, Davis EB, Zhang X, Cockcroft DW. Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol. J Allergy Clin Immunol 2000; 106: 57-64.
11. Bruno G, Andreozzi P, Bracchitta S, Graf U, Santangelo G, Zaino S, Gaston N. Serum tryptase in allergic rhinitis: effect of cetirizine and fluticasone propionate treatment. Clin Ter 2001; 152: 299-303.
12. He S, Walls AF. Human mast cell tryptase: a potent stimulus of microvascular leakage and mast cell activation. Eur J Pharmacol 1997; 328: 89-97.
13. Barrios VE, Middleton SC, Kashem MA, Havill AM, Toombs CF, Wright CD. Tryptase mediates hyperresponsiveness in isolated guinea pig bronchi. Life Sci 1998; 63:2295-303.
14. Forteza RM, Ahmed A, Lee T, Abraham WM. Secretory leukocyte protease inhibitor, but not alpha-1 protease inhibitor, blocks tryptase-induced bronchoconstriction. Pulm Pharmacol Ther 2001; 14: 107-10.
15. Cairns JA, Walls AF. Mast cell tryptase is a mitogen for epithelial cells: stimulation of IL-8 produdtion and intercellular adhesion molecule-1 expression. J Immunol 1996; 156: 275-83.
16. He S, Peng Q, Walls AF. Potent induction of neutrophil- and eosinophil-rich infiltrate in vivo by human mast cell tryptase: selective enhancement of eosinophil recruitment by histamine. J Immunol 1997; 159: 6216-25.
17. Schwartz LB, Metcalfe DD, Miller JS, Earl H, Sullivan T. Tryptase levels as an indicator of mast cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med 1987; 316: 1622-26.
18. Meltzer EO, Orgel HA, Jalowayski AA. Histamine levels and nasal cytology in children with chronic otitis media and rhinitis. Ann Allergy Asthma Immunol 1995; 74: 406-10.
19. Rijcken B, Schouten JP, Xu X, Rosner B, Weiss ST. Airway hyperresponsiveness to histamine associated with accelerated decline in FEV1. Am J Respir Crit Care Med 1995; 151: 1377-82.
20. Jarjour NN, Calhoun WJ, Schwartz LB, Busse WW. Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with increased airway obstruction. Am Rev Respir Dis 1991; 144: 83-7.
21. He S, Gaça MDA, Walls AF. A role for tryptase in the activation of human mast cells: modulation of histamine release by tryptase and inhibitors of tryptase. J Pharmacol Exp Ther 1998; 286: 289-97.
22. He S, McEuen AR, Blewett SA, Li P. Buckley MG, Leufkens P, Walls AF. The inhibition of mast cell activation by neutrophil lactoferrin: uptake by mast cells and interaction with tryptase, chymase and cathepsin G. Biochem Pharmacol 2003; 65: 1007-15.
23. He S, Gaça MDA, McEuen AR, Walls AF. Inhibitors of chymase as mast cell stabilising agents: the contribution of chymase in the activation of human mast cells. J Pharmacol Exp Ther 1999; 291: 517-23.
24. He S, Gaca MD, Walls AF. The activation of synovial mast cells: modulation of histamine release by tryptase and chymase and their inhibitors. Eur J Pharmacol 2001; 412: 223-9.
25. He S, Xie H. Modulation of histamine release from human colon mast cells by protease inhibitors. World J Gastroenterol 2003; (submitted).
26. He S, Xie H, He YS. Induction of tryptase and histamine release from human colon mast cells by IgE-dependent or-independent mechanisms. World J Gastroenterol 2003; (submitted).
27. Buckley M, Walters C, Brander M, Wong WM, Cawley MI, Ren S, Schwartz LB, Walls AF. Mast cell activation in arthritis: detection of tryptase, histamine and eosinophil cationic protein in synovial fluid. Clin Sci 1997; 93: 363-70.
28. He S, Chen P, Chen HQ. Modulation of enzymatic activity of human mast cell tryptase and chymase by proteinase inhibitors. Acta Pharmacol Sin 2003; 24: 923-9.
29. Yanagida M, Fukamachi H, Takei M, Uzumaki H, Saito TT, Iikura Y, Nakahata T. Effect of a chymotrypsin-like inhibitor, TPCK, on histamine release from cultured human mast cells. J Pharm Pharmacol 1997; 49: 537-41.
30. Hultsch T, Ennis M, Heidtmann HH. The effect of serine esterase inhibitors on ionophore-induced histamine release from human pulmonary mast cells. Agents Actions 1988; 23: 198-200.
31. Foreman JC, Mongar JL, Gomperts BD. Calcium ionophores and movement of calcium ions following the physiological stimulus to a secretory process. Nature 1973; 245: 249-51.
32. Hallgren J, Estrada S, Karlson U, Alving K, Pejler G. Heparin antagonists are potent inhibitors of mast cell tryptase. Biochemistry 2001; 40: 7342-9.
33. Augusto C, Lunardi LO, Vugman I. Non-cytotoxic guinea-pig mesenteric mast cell stimulation by protamine. Agents Actions 1987; 22: 185-8.
34. Augusto C, Lunardi LO, Vugman I. Reduction in rat mesentery mast cell staining after degranulation by protamine. A competitive antagonism. Cell Mol Biol 1990; 36: 357-61.
35. Porsche R, Brenner ZR. Allergy to protamine sulfate. Heart Lung 1999; 28: 418-28.
36. Rich DH, Moon BJ, Harbeson S. Inhibition of aminopeptidases by amastatin and bestatin derivatives. Effect of inhibitor structure on slow-binding processes. J Med Chem 1984; 27: 417-22.
37. Krishna MT, Chauhan A, Little L, Sampson K, Hawksworth R, Mant T, Djukanovic R, Lee T, Holgate ST. Inhibition of mast cell tryptase by inhaled APC366 attenuates allergen-induced late-phase airway obstruction in asthma. J Allergy Clin Immunol 2001; 107: 1039-45.
38. Tremaine WJ, Brzezinski A, Katz JA, Wolf DC, Fleming TJ, Mordenti J, Strenkoski-Nix LC, Kurth MC. Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC2059): an open-label pilot study. Aliment Pharmacol Ther 2002; 16: 407-13.